drug combination
452 articles
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
Reducing Pancreatic Cancer Risk Through Chemoprevention
Dr. Peter Allen leads a clinical trial of chemoprevention–the use of a medication to prevent IPMNs from developing into pancreatic cancer.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
KRYSTAL-1 Trial Shows Promising Activity in Pancreas and Other GI Cancers
Dr. Tanios Bekaii-Saab reports promising results of the KRYSTAL-1 trial, which targets a KRAS mutation common to pancreatic cancer.
How Could This Happen to Me?
Michael Bailey felt his world turn sideways after a diagnosis of acinar cell pancreatic cancer. He had a pancreatectomy and chemotherapy.
Is Pancreatic Cancer Different in Black Patients?
Pancreatic cancer occurs at a higher rate in Black patients. Dr. Howard Crawford leads a study looking at the cancer biology for differences.
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
Practical Tips For Patients In Treatment
Long-term survivor and patient advocate Steven Merlin has a host of practical tips for patients to help manage life during treatment.
Determined to Win
After a metastatic pancreatic cancer diagnosis, Linda Chambless sought a second opinion, which led her to a clinical trial.
RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites
Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.
Education, Clinical Trials, and Advocacy
Pat Theobald lost her mother to pancreatic cancer, so when she received the same diagnosis she knew to start treatment with a clinical trial.
A Longer Plan with Treatment Options
Susan Riddle had chemotherapy and radiation before she qualified for NanoKnife treatment, all to control her pancreatic cancer.
Facing Pancreatic Cancer and Making the Most of Borrowed Time
With a young family, Justin Baker is hoping for more time because he has a genetic mutation that favors certain treatments.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.
Treating BRCA-Negative Pancreatic Cancer Patients with a Family Cancer History Similar to BRCA Carriers
A clinical trial looks at the effectiveness of a PARP inhibitor in BRCA-negative pancreatic cancer patients with a family history BRCA-type cancers.